mhurhangee/ep-ind-claims huggingface dataset:
Movement arrangement for a door handle arrangement, comprising a connecting lever for connection to a door handle, a spring tensioning lever, a restoring spring and an eccentric unit, the connecting lever and the spring tensioning lever being mounted pivotably about a common pivot axle and being pivotable relative to one another about this pivot axle, the restoring spring being coupled to a spring bearing region of the connecting lever and to a spring bearing region of the spring tensioning lever in such a way that it is relievable by way of the pivoting movement of the spring bearing region of the spring tensioning lever in the direction of the spring bearing region of the connecting lever and is tensionable by way of the opposite pivoting movement, the eccentric unit being mounted rotatably and having a connecting lever eccentric cam for guiding the connecting lever and a spring tensioning lever eccentric cam for guiding the spring tensioning lever, and the eccentric cams (12, 13) being configured in such a way that - the movement arrangement is transferable from a retracted position into an extended position by way of rotation of the eccentric unit, - the connecting lever and the spring tensioning lever are positioned relative to one another in the retracted position and the extended position in such a way that the restoring spring is partially tensioned, - the connecting lever bears against the connecting lever eccentric cam during the rotational movement of the eccentric unit, and - the spring tensioning lever bears against the spring tensioning lever eccentric cam in the retracted position and in the extended position and is spaced apart from the spring tensioning lever eccentric cam in between. - the movement arrangement is transferable from a retracted position into an extended position by way of rotation of the eccentric unit, - the connecting lever and the spring tensioning lever are positioned relative to one another in the retracted position and the extended position in such a way that the restoring spring is partially tensioned, - the connecting lever bears against the connecting lever eccentric cam during the rotational movement of the eccentric unit, and - the spring tensioning lever bears against the spring tensioning lever eccentric cam in the retracted position and in the extended position and is spaced apart from the spring tensioning lever eccentric cam in between.
A combination including a holder for handling and delivering a prosthetic mitral heart valve to an implantation site, comprising: a prosthetic mitral heart valve having an inflow end and three flexible commissures ending in tips projecting in an outflow direction; a holder body contacting the inflow end of the heart valve, the holder body defining a central window through which leaflets of the valve are visible; connecting sutures each fixed to the holder body and extending from the holder body along each of the commissure posts of the valve, the connecting sutures crossing between the tips of the commissure posts; a tensioning mechanism on the holder for applying tension to the connecting sutures to cause the commissure post tips to move radially inward, characterized in that the combination further comprises a handle attached adjacent a peripheral edge of the holder and angling radially outward therefrom. a prosthetic mitral heart valve having an inflow end and three flexible commissures ending in tips projecting in an outflow direction; a holder body contacting the inflow end of the heart valve, the holder body defining a central window through which leaflets of the valve are visible; connecting sutures each fixed to the holder body and extending from the holder body along each of the commissure posts of the valve, the connecting sutures crossing between the tips of the commissure posts; a tensioning mechanism on the holder for applying tension to the connecting sutures to cause the commissure post tips to move radially inward, characterized in that the combination further comprises a handle attached adjacent a peripheral edge of the holder and angling radially outward therefrom.
A laser diode, comprising a substrate and a stacked layer on the substrate, the stacked layer comprising an N-type layer, an active layer, a P-type layer with a ridge-shaped strip on a surface thereof, and a laterally plated DBR cladding layer, characterized in that an end surface of the ridge-shaped strip along a length direction of the ridge-shaped strip is a first inclined surface which is inclined with respect to both a normal direction of a lower surface of the ridge-shaped strip and an emission end surface of the laser diode, and a contact surface of the ridge-shaped strip in contact with the DBR cladding layer comprises the first inclined surface.
A computer implemented method for improved quality assurance in pathology comprising: scanning a glass slide in accordance with a set of scanning parameters to create a digital slide image of a tissue sample, the tissue sample being disposed on the surface of the glass slide, wherein the tissue sample comprises at least one stain; digitally analyzing the digital slide image to assess the quality of the digital slide image; comparing the assessed quality of the digital slide image to a set of predetermined criteria; determining whether the quality of the digital slide image meets the set of predetermined criteria, wherein the determination comprises determining whether the slide is over-stained; if it is determined that the quality of the digital slide image meets the set of predetermined criteria, providing the digital slide image on a digital image viewer; and if it is determined that the slide is over-stained, automatically digitally rescanning the over-stained glass slide with less light to create a second digital slide image of the tissue sample. scanning a glass slide in accordance with a set of scanning parameters to create a digital slide image of a tissue sample, the tissue sample being disposed on the surface of the glass slide, wherein the tissue sample comprises at least one stain; digitally analyzing the digital slide image to assess the quality of the digital slide image; comparing the assessed quality of the digital slide image to a set of predetermined criteria; determining whether the quality of the digital slide image meets the set of predetermined criteria, wherein the determination comprises determining whether the slide is over-stained; if it is determined that the quality of the digital slide image meets the set of predetermined criteria, providing the digital slide image on a digital image viewer; and if it is determined that the slide is over-stained, automatically digitally rescanning the over-stained glass slide with less light to create a second digital slide image of the tissue sample.
A purification method comprising: - providing a flow comprising a glycol, monovalent ions and multivalent ions; - treating this flow with ion exclusion chromatography comprising: ▪ injecting the flow into a chromatographic unit comprising an ion exchange stationary phase; ▪ injecting an eluent into the chromatographic unit; ▪ collecting a fraction at the outlet of the chromatographic unit; - optionally, a subsequent step of concentrating the collected fraction; the collected fraction being enriched with glycol and depleted of monovalent ions and multivalent ions relative to the flow. - providing a flow comprising a glycol, monovalent ions and multivalent ions; - treating this flow with ion exclusion chromatography comprising: ▪ injecting the flow into a chromatographic unit comprising an ion exchange stationary phase; ▪ injecting an eluent into the chromatographic unit; ▪ collecting a fraction at the outlet of the chromatographic unit; ▪ injecting the flow into a chromatographic unit comprising an ion exchange stationary phase; ▪ injecting an eluent into the chromatographic unit; ▪ collecting a fraction at the outlet of the chromatographic unit; - optionally, a subsequent step of concentrating the collected fraction; the collected fraction being enriched with glycol and depleted of monovalent ions and multivalent ions relative to the flow.
Combined device comprising a hob and extractor device, integrated in the hob, with an intake opening, wherein the hob has at least one cover plate (100, 101) and at least one heating module (102, 103) arranged below the at least one cover plate (100, 101), wherein the combined device has a frame, characterised in that the hob has at least two cover plates (100, 101), which together form the surface of the hob, of which at least one cover plate (101, 101) is guided displaceably in the frame of the combined device, at least one of the cover plates (100, 101), in at least one position, upwardly covers at least part of the intake opening of the extractor device, the at least two cover plates are arranged in the same horizontal plane and are arranged adjacent to one another.
A monoclonal antibody or a fragment or derivative thereof which comprises the binding domain of the monoclonal antibody, that specifically binds to Cadherin-17 comprising the sequence of SEQ ID NO: 1, wherein said monoclonal antibody contains or is conjugated to a therapeutic moiety for use in the treatment or prevention of colorectal cancer.
A composition, comprising: a. cannabinoid receptor binding agents present at about 1% to about 55% by weight of the composition, wherein the cannabinoid receptor binding agents are selected from the group consisting of a cannabinoid receptor agonist, a cannabinoid receptor antagonist, a chemically modified cannabinoid receptor agonist, and a chemically modified cannabinoid receptor antagonist; and b. particles attached to the cannabinoid receptor binding agents, wherein the particles are present at about 75% by weight of the composition or less, and wherein the particles at their largest dimensions are smaller than about 1000 nanometers. a. cannabinoid receptor binding agents present at about 1% to about 55% by weight of the composition, wherein the cannabinoid receptor binding agents are selected from the group consisting of a cannabinoid receptor agonist, a cannabinoid receptor antagonist, a chemically modified cannabinoid receptor agonist, and a chemically modified cannabinoid receptor antagonist; and b. particles attached to the cannabinoid receptor binding agents, wherein the particles are present at about 75% by weight of the composition or less, and wherein the particles at their largest dimensions are smaller than about 1000 nanometers.
A transmission device, comprising: a light source; and a transmitter configured to generate modulated signals based on input signals and transmit the modulated signals from the light source as visible light by changing a luminance of the light source in accordance with the modulated signals; characterized in that the modulated signals include a plurality of frame groups corresponding to a plurality of access points in a wireless local area network, LAN, wherein each frame group corresponds to one of the access points and includes one or more frames, each of the one or more frames including information related to a service set identifier, SSID, of the access point corresponding to the frame group including the frame; and the transmitter is configured to transmit the frame groups at different times. a light source; and a transmitter configured to generate modulated signals based on input signals and transmit the modulated signals from the light source as visible light by changing a luminance of the light source in accordance with the modulated signals; characterized in that the modulated signals include a plurality of frame groups corresponding to a plurality of access points in a wireless local area network, LAN, wherein each frame group corresponds to one of the access points and includes one or more frames, each of the one or more frames including information related to a service set identifier, SSID, of the access point corresponding to the frame group including the frame; and the transmitter is configured to transmit the frame groups at different times.
A memory cell (200, 300) arranged in a monolithic stack, comprising: a bottom electrode (206, 302) formed of a bottom electrode material that comprises_an electrically conductive metal, metal alloy, a TiN material or a TaN material; a switching medium (208, 304) formed on and in contact with the electrically conductive metal, metal alloy, TiN material or TaN material of the bottom electrode material, the switching medium comprising an electrically resistive material selected from a group consisting of: a silicon oxide, silicon suboxide: SiOx where 0.1<x<2, metallic oxide, ZnOx, TaOx, HfOx, NiOx, WOx, AlOx, CuOx, and GeOx; a top electrode (212, 308) comprising a conductive metal that produces metallic ions at a surface closest to the switching medium in response to an electric field applied to the memory cell, wherein the switching medium is at least in part permeable to the ions; and a passivation layer (214, 310) comprising a non-noble metal disposed at an opposite side of the top electrode from the switching medium, wherein the passivation layer has a thickness in a range of 10 nm to 50 nm and reduces diffusion of one or more atmospheric gasses into the top electrode. a bottom electrode (206, 302) formed of a bottom electrode material that comprises_an electrically conductive metal, metal alloy, a TiN material or a TaN material; a switching medium (208, 304) formed on and in contact with the electrically conductive metal, metal alloy, TiN material or TaN material of the bottom electrode material, the switching medium comprising an electrically resistive material selected from a group consisting of: a silicon oxide, silicon suboxide: SiOx where 0.1<x<2, metallic oxide, ZnOx, TaOx, HfOx, NiOx, WOx, AlOx, CuOx, and GeOx; a top electrode (212, 308) comprising a conductive metal that produces metallic ions at a surface closest to the switching medium in response to an electric field applied to the memory cell, wherein the switching medium is at least in part permeable to the ions; and a passivation layer (214, 310) comprising a non-noble metal disposed at an opposite side of the top electrode from the switching medium, wherein the passivation layer has a thickness in a range of 10 nm to 50 nm and reduces diffusion of one or more atmospheric gasses into the top electrode.
A method for mobile data offloading of a mobile device between an access point of a 3GPP network and an access point of a non 3GPP network, where either an access point (FAP1, FAP2) of said 3GPP network or an access point (WAP1, WAP2) of said non-3GPP access point provides said mobile device with internet access, said mobile data offloading being under control of a management centre, being coupled to each access point (FAP1, FAP2) of said 3GPP network, to each access point (WAP1, WAP2) of said non-3GPP network and being coupled to said at least one mobile device, characterized in that said method comprises the steps of: - collecting at least one access point performance parameter corresponding to at least one access point of said 3GPP networks and corresponding to at least one access point of said non-3GPP networks by at least one mobile device; and - said at least one mobile device communicating said at least one access point performance parameter corresponding to said 3GPP access points and corresponding to said non 3GPP access points to said management center; and - said management centre generating an access point overview based on said at least one access point performance parameter corresponding to said 3GPP access points (FAP1, FAP2) and corresponding to said and non 3GPP access points (WAP1, WAP2); and - generating a management action based on said access point overview. - collecting at least one access point performance parameter corresponding to at least one access point of said 3GPP networks and corresponding to at least one access point of said non-3GPP networks by at least one mobile device; and - said at least one mobile device communicating said at least one access point performance parameter corresponding to said 3GPP access points and corresponding to said non 3GPP access points to said management center; and - said management centre generating an access point overview based on said at least one access point performance parameter corresponding to said 3GPP access points (FAP1, FAP2) and corresponding to said and non 3GPP access points (WAP1, WAP2); and - generating a management action based on said access point overview.
A method of purifying monoclonal antibodies, said method including the steps of: a) following production of antibodies in a source organism, harvesting monoclonal antibody sources from the source organism; b) extracting said antibodies from said source organism with an extraction formulation comprising an alkaline buffer, an antioxidant and a chelating agent, and clarifying the antibodies; c) processing said extracted and clarified antibodies through a series of chromatography separation procedures, i) wherein a first procedure includes an affinity column from which the target antibody is eluted with an arginine-containing acidic buffer to form an eluent containing full-length monomeric antibody structures, ii) wherein a second procedure includes an ion-exchange column for separating and collecting the full-length antibody monomeric structures from the eluent of step "c(i)", and iii) wherein a third procedure includes a multimodal column from which the target antibody is eluted over a gradient established between at least one salt, during which the monomeric antibody structures are collected; d) subjecting the collected antibody structures from step "c(iii)" to a buffer extraction step; e) filtering said collected antibody structure fraction through a multiple filter press operation; and f) collecting the resultant filtered monoclonal antibody formulations and storing the same for utilization as a bulk drug substance; wherein before performing step "c(ii)" the antibody eluent of step "c(i)"is neutralized to a pH that is at least 0.2 units below the isoelectric point for the antibody. a) following production of antibodies in a source organism, harvesting monoclonal antibody sources from the source organism; b) extracting said antibodies from said source organism with an extraction formulation comprising an alkaline buffer, an antioxidant and a chelating agent, and clarifying the antibodies; c) processing said extracted and clarified antibodies through a series of chromatography separation procedures, i) wherein a first procedure includes an affinity column from which the target antibody is eluted with an arginine-containing acidic buffer to form an eluent containing full-length monomeric antibody structures, ii) wherein a second procedure includes an ion-exchange column for separating and collecting the full-length antibody monomeric structures from the eluent of step "c(i)", and iii) wherein a third procedure includes a multimodal column from which the target antibody is eluted over a gradient established between at least one salt, during which the monomeric antibody structures are collected; d) subjecting the collected antibody structures from step "c(iii)" to a buffer extraction step; e) filtering said collected antibody structure fraction through a multiple filter press operation; and f) collecting the resultant filtered monoclonal antibody formulations and storing the same for utilization as a bulk drug substance;
Motorcycle to be operated on a ground comprising a seat, an engine, a gear case, a body frame which extends longitudinally along the body of the motorcycle, a shock absorber, and an air intake structure for the engine, said air intake structure is mounted on the gear case and comprises: an intake chamber; an outlet chamber; a connecting pipe, one end thereof being connected to the outlet chamber, the other end thereof being connectable to the engine; and an intake pipe, wherein the intake pipe is tilted towards the connecting pipe, characterized in that a side of the air intake structure is connected to the shock absorber. an intake chamber; an outlet chamber; a connecting pipe, one end thereof being connected to the outlet chamber, the other end thereof being connectable to the engine; and an intake pipe, wherein the intake pipe is tilted towards the connecting pipe, characterized in that a side of the air intake structure is connected to the shock absorber.
A chain link comprising a strip comprising a longitudinal core section and at least two longitudinal edge sections, wherein the thickness of the core section is higher than the thickness of the edge sections, characterized in that the strip contains a warp yarn A and a warp yarn B, with the titer of warp yarn A being higher than the titer of warp yarn B.
A liquid composition comprising: - a liquid medium comprising at least one aprotic polar organic solvent and less than 25 wt% based on the total weight of the composition of an alcohol; and - at least 5 wt% based on the total weight of the composition of at least one fluorinated anion exchange polymer under dissolved or dispersed form, said polymer comprising a fluorocarbon backbone and side-chains covalently attached to the backbone having terminal groups of formula: - SO 2 NR 1 Q + X-, wherein Q + is a group comprising at least one quaternary nitrogen atom, and R 1 is H or a C 1 -C 20 alkyl group, or forms a ring together with a group in Q +, wherein the ring contains 2 to 10 carbon atoms and, optionally, up to 4 heteroatoms; and X- is NO 3 - or an organic anion selected from the group consisting of R A1 SO 3 -, wherein R A1 is a C 1 -C 20 linear or branched, optionally fluorinated, alkyl or substituted or non-substituted aryl group, and of R A2 COO -, wherein R A2 is a C 1 -C 20 linear or branched, optionally fluorinated, alkyl or substituted or non-substituted aryl group. - a liquid medium comprising at least one aprotic polar organic solvent and less than 25 wt% based on the total weight of the composition of an alcohol; and - at least 5 wt% based on the total weight of the composition of at least one fluorinated anion exchange polymer under dissolved or dispersed form, said polymer comprising a fluorocarbon backbone and side-chains covalently attached to the backbone having terminal groups of formula: - SO 2 NR 1 Q + X-, wherein Q + is a group comprising at least one quaternary nitrogen atom, and R 1 is H or a C 1 -C 20 alkyl group, or forms a ring together with a group in Q +, wherein the ring contains 2 to 10 carbon atoms and, optionally, up to 4 heteroatoms; and X- is NO 3 - or an organic anion selected from the group consisting of R A1 SO 3 -, wherein R A1 is a C 1 -C 20 linear or branched, optionally fluorinated, alkyl or substituted or non-substituted aryl group, and of R A2 COO -, wherein R A2 is a C 1 -C 20 linear or branched, optionally fluorinated, alkyl or substituted or non-substituted aryl group.